HIGHLIGHTS
- who: Xingchun Wang from the Central Michigan University, United States have published the Article: Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease, in the Journal: (JOURNAL)
- what: The aim of this study was to evaluate the effects of sitagliptin on IHL in NAFLD patients. Informed consent was obtained from each participant after being informed of the aims of the study and potential adverse effects of the study drugs. The subjects included in this study had either no history of alcohol consumption or their alcohol intake was less than . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.